Raymond James & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $128M | Sell |
|
|||||
|
2024
Q2 | $135M | Sell |
|
|||||
|
2024
Q1 | $212M | Sell |
|
|||||
|
2023
Q4 | $229M | Sell |
|
|||||
|
2023
Q3 | $204M | Sell |
|
|||||
|
2023
Q2 | $207M | Sell |
|
|||||
|
2023
Q1 | $223M | Sell |
|
|||||
|
2022
Q4 | $302M | Buy |
|
|||||
|
2022
Q3 | $301M | Sell |
|
|||||
|
2022
Q2 | $295M | Sell |
|
|||||
|
2022
Q1 | $331M | Sell |
|
|||||
|
2021
Q4 | $353M | Sell |
|
|||||
|
2021
Q3 | $294M | Buy |
|
|||||
|
2021
Q2 | $272M | Buy |
|
|||||
|
2021
Q1 | $238M | Buy |
|
|||||
|
2020
Q4 | $206M | Buy |
|
|||||
|
2020
Q3 | $170M | Sell |
|
|||||
|
2020
Q2 | $242M | Buy |
|
|||||
|
2020
Q1 | $207M | Sell |
|
|||||
|
2019
Q4 | $262M | Sell |
|
|||||
|
2019
Q3 | $228M | Buy |
|
|||||
|
2019
Q2 | $185M | Buy |
|
|||||
|
2019
Q1 | $153M | Buy |
|
|||||
|
2018
Q4 | $160M | Buy |
|
|||||
|
2018
Q3 | $180M | Buy |
|
|||||
|
2018
Q2 | $119M | Sell |
|
|||||
|
2018
Q1 | $123M | Buy |
|
|||||
|
2017
Q4 | $103M | Sell |
|
|||||
|
2017
Q3 | $127M | Buy |
|
|||||
|
2017
Q2 | $123M | Buy |
|
|||||
|
2017
Q1 | $114M | Buy |
|
|||||
|
2016
Q4 | $77.9M | Buy |
|
|||||
|
2016
Q3 | $83.5M | Sell |
|
|||||
|
2016
Q2 | $90.2M | Buy |
|
|||||
|
2016
Q1 | $91.9M | Buy |
|
|||||
|
2015
Q4 | $80.8M | Buy |
|
|||||
|
2015
Q3 | $74.2M | Buy |
|
|||||
|
2015
Q2 | $72.7M | Buy |
|
|||||
|
2015
Q1 | $58.8M | Buy |
|
|||||
|
2014
Q4 | $52.6M | Buy |
|
|||||
|
2014
Q3 | $36.9M | Buy |
|
|||||
|
2014
Q2 | $32.8M | Buy |
|
|||||
|
2014
Q1 | $31.5M | Sell |
|
|||||
|
2013
Q4 | $30.3M | Buy |
|
|||||
|
2013
Q3 | $19.8M | Buy |
|
|||||
|
2013
Q2 | $18.6M | Buy |
|